Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Clearside Biomedical, Inc. Director's Dealing 2024

Mar 18, 2024

34933_dirs_2024-03-18_449a1043-32b5-42b4-bd71-6485f2c9a91e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Clearside Biomedical, Inc. (CLSD)
CIK: 0001539029
Period of Report: 2024-03-14

Reporting Person: Chong Ngai Hang Victor (N/A)

More from Clearside Biomedical, Inc.

Regulatory Filings 2026
Jan 7
Regulatory Filings 2025
Dec 29
Regulatory Filings 2025
Dec 17
Regulatory Filings 2025
Dec 17
Regulatory Filings 2025
Dec 15
Regulatory Filings 2025
Dec 15
Regulatory Filings 2025
Dec 15
Regulatory Filings 2025
Dec 15
Regulatory Filings 2025
Dec 15
Regulatory Filings 2025
Dec 15
View all filings →